The Indian Government refuted the attempt by a multinational company (MNC) to patent the antiseptic property of curcumin derived from turmeric. Analyse the unethical practice adopted by the MNC, state its implications, and suggest provisions in Indian law to prevent such malpractices.
Previous Year Questions · Question 28 of 37
The Indian Government refuted the attempt by a multinational company (MNC) to patent the antiseptic property of…
Question 283 marksAsked 2018Hard
The practice: biopiracy. Turmeric's healing use is part of India's traditional knowledge. Patenting it is "the use of bio-resources by multinational companies and other organisations without proper authorisation from the countries and people concerned without compensatory payment".
Implications:
- India's farmers and communities, who developed the knowledge, would get no compensation or benefit.
- The patent could restrict others, even in India, from selling or using the product.
- Other countries could "encash on our rich legacy".
Provisions in Indian law: the Indian Parliament cleared the second amendment of the Indian Patents Bill, which takes such issues into consideration, including patent terms, emergency provisions, and research and development initiatives. Such laws prevent unauthorised exploitation of bio-resources and traditional knowledge.
